BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1444484)

  • 1. [Blood concentrations of futraful, uracil and 5-fluorouracil (5-FU) after UFT administration in the various reconstructions after gastrectomy. Saitama UFT Research Group].
    Suda Y; Uchida K; Okamura H; Oshima Y; Shimizu M; Miyakawa T; Okubo S; Shiina E; Hosoda Y; Tokura Y
    Gan To Kagaku Ryoho; 1992 Nov; 19(13):2181-7. PubMed ID: 1444484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Blood levels of 5-FU and uracil on additional use of uracil in UFT therapy in gastrectomized patients].
    Suda Y; Uchida K
    Gan To Kagaku Ryoho; 1995 Sep; 22(10):1343-7. PubMed ID: 7668868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of gastrectomy on serum 5-FU concentrations of patients administered UFT per os].
    Yamamoto Y; Amano T; Fujimoto Y; Imada T; Tamura S; Noguchi Y; Matsumoto A
    Gan No Rinsho; 1987 Apr; 33(4):377-81. PubMed ID: 3106673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A study of urinary tegafur, 5-fluorouracil (5-FU) and uracil concentrations in the cases of gastric carcinoma for the confirmation of drug-taking compliance after UFT oral administration].
    Ohsawa S; Kondo Y; Shiroto H; Masuko H; Fukushima T; Kataoka A; Ohmori K; Sawaguchi Y; Baba E; Takahashi T
    Gan To Kagaku Ryoho; 1992 Nov; 19(13):2189-93. PubMed ID: 1444485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study on the concentrations of 5-fluorouracil (5-FU), tegafur (ET) and uracil in bile: comparison of UFT or FT].
    Tomita T; Tajima T; Ishibashi M; Tagaya N; Aoki H; Itoh S; Kadowaki A; Kogure H; Tajima Y
    Gan To Kagaku Ryoho; 1989 Dec; 16(12):3755-62. PubMed ID: 2512859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The serum and tissue concentrations of tegafur, 5-fluorouracil and uracil in patients with gastric and colorectal cancers after oral administration of UFT].
    Takahashi N; Nitta A; Saitou T; Mori Y; Kunii Y; Kikuchi K
    Gan To Kagaku Ryoho; 1988 Aug; 15(8):2319-23. PubMed ID: 3136701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Concentration of 5-fluorouracil in the blood and tissues of gastric and colo-rectal cancer patients after oral administration of UFT].
    Inaba S; Kondo Y; Tsuchiya K; Kawai K; Ogino A; Umeda T; Ueda Y
    Gan To Kagaku Ryoho; 1992 Nov; 19(13):2175-80. PubMed ID: 1444483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Blood and tumor levels of tegafur, 5-fluorouracil, and uracil].
    Takeshita T; Iwasaki M; Narita M; Sou M; Sato M; Hashimoto T; Kameya S; Iigima N
    Gan To Kagaku Ryoho; 1988 Nov; 15(11):3053-8. PubMed ID: 3142365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [5-FU concentration in tissues of gastric cancer patients with preoperative administration of UFT--especially in comparison with FT-207].
    Takeshita M; Ishikawa H; Seki M; Ikeya T; Miyamoto Y; Izuo M; Tozuka S; Usui R; Kaneko H
    Gan No Rinsho; 1985 Oct; 31(13):1697-703. PubMed ID: 3935831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacokinetic study of UFT in cancer patients receiving maintenance dialysis].
    Sakamoto K; Arita S; Hisikawa E; Yaguchi H; Arima H; Matsumoto M; Hachisu T; Kashiwabara H; Yokoyama T
    Gan To Kagaku Ryoho; 1995 Feb; 22(2):239-44. PubMed ID: 7857099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1-(2'-tetrahydrofuryl)-5-fluorouracil.
    Ho DH; Pazdur R; Covington W; Brown N; Huo YY; Lassere Y; Kuritani J
    Clin Cancer Res; 1998 Sep; 4(9):2085-8. PubMed ID: 9748123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [5-FU, FT-207 and uracil concentrations in the serum and tissues of patients with cervical cancer after UFT oral administration].
    Tanimura T; Kaneshige E; Fujiwara K; Kobashi Y; Inoue K; Kono I; Sekiba K
    Gan To Kagaku Ryoho; 1986 Feb; 13(2):349-55. PubMed ID: 3080967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies on 5-FU concentration in serum and prostate cancer tissue after oral administration of UFT].
    Shinoda I; Takahashi Y; Takeuchi T; Kuriyama M; Ban Y; Kawada Y; Ito Y; Yamamoto N; Maeda S; Tada K
    Hinyokika Kiyo; 1991 Jul; 37(7):711-5. PubMed ID: 1927771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Level of 5-FU in tumor tissues of the patients with head and neck malignant tumors after oral administration of UFT].
    Kusama M; Utsunomiya Y; Ono T; Nagura H; Enomoto S
    Gan To Kagaku Ryoho; 1983 Aug; 10(8):1796-802. PubMed ID: 6411004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [5-FU concentration in blood and tissue of patients with renal cell carcinoma after administration of UFT].
    Masuda F; Suzuki M; Ohnishi T; Nakada J; Mori Y; Iizuka N; Machida T
    Gan To Kagaku Ryoho; 1985 Feb; 12(2):320-4. PubMed ID: 3918507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long-term administration of tegafur in postoperative adjuvant chemotherapy in gastric cancer patients. Serial analysis of serum tegafur and 5-fluorouracil concentrations, and influence from PSK combination].
    Tanaka T; Kitao T; Furutani M; Harada T; Hayashi S; Matsushita T; Asada I; Shirosaki H
    Gan To Kagaku Ryoho; 1989 Jan; 16(1):95-9. PubMed ID: 2492184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [FT, 5-FU and uracil concentrations of the blood, bile and tissue of hepatoma with liver cirrhosis after oral administration of UFT].
    Oguma S; Sakai K; Sato R; Ouchi K; Owada Y; Sato T
    Gan To Kagaku Ryoho; 1987 Apr; 14(4):1122-8. PubMed ID: 3032114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [5-FU concentration in the blood and tissue of patients with gastric and colorectal cancer after administration of UFT or tegafur].
    Arima S; Futami K; Shigeta M; Kinashi M; Shimura H
    Gan To Kagaku Ryoho; 1986 Aug; 13(8):2618-24. PubMed ID: 3090940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tissue UFT distribution and histological changes following UFT administration in metastatic liver cancer cases].
    Yoshikawa K; Iwasaki T; Amemiya A; Emoto T; Fujii M; Han N; Itou A; Tsujimura T
    Gan To Kagaku Ryoho; 1990 Jul; 17(7):1333-7. PubMed ID: 2114828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of OK-432 on UFT activation].
    Yamamoto Y; Amano T; Imada T; Tamura S; Abe M; Matsumoto A
    Gan No Rinsho; 1988 May; 34(6):749-54. PubMed ID: 3132564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.